Navigation Links
New Blood Test to Diagnose Parkinson Disease

Researchers in Melbourne have found a breakthrough method of blood test to diagnose Parkinson disease. This test is done by measuring the proteins //in blood much before the symptoms arrive. The test is done by a team of Howard Florey Institute, Mental Health Research Institute and Melbourne University specialists.

They have also created a genetic test for PD which has a broader application as it can screen many types of PD and monitor treatment for it. It can also monitor the effectiveness of the medicines used to treat the disease.

The research will pave the way for the development of new drugs for the disease or even delay the disease to some extent. The researchers are hopeful that within two years they would be able to make available the test to public who are at risk of developing it. It will be cheaper and quicker results could be achieved.

Dr Qiao-Xin Li and colleagues from The University of Melbourne and The Mental Health Research Institute of Victoria, along with Prof Malcolm Horne from the Howard Florey Institute, found people with PD had low levels of the brain-secreted protein 'alpha-synuclein' in their blood, while people without PD had high levels of the protein.

It is also the first test which is able to differentiate between those who will get it and those who will not.

“Currently there is no specific PD diagnostic test so doctors rely on their observations to make a diagnosis, which means some patients may not be prescribed the most suitable medication and around 15% of those diagnosed may actually be suffering from something else,” Prof Horne said. He says “if we can first understand why people with Parkinson's have this low protein level, then drugs can be designed to actually stop the process.”

In the next few months clinical trials will begin involving 150 Australians. Parkinson disease is second most common neurodegenerative disorder affecting 1% of the Australian population
'"/>




Page: 1 2

Related medicine news :

1. Recommendations for Treatment of Blood Pressue
2. Blood Cells Capable of Regenerating Liver
3. Blood clots likely in long travel
4. Hemochromatosis Patients Blood is Safe
5. Blood transfusions beneficial after heart attacks
6. Blood Pressure Drug may slow wasting in burn victims
7. Levels Of Blood Proteins May Help Heart Disease Care
8. Blood test may identify ovarian cancer
9. A Blood test for suicide risk?
10. Blood Pressure Drugs maintain muscle strength
11. Blood test diagnoses heart failure in short time
Post Your Comments:
(Date:5/16/2008)...l HIV Vaccine Awareness Day, May,18, WASHINGTON, ... into the,AIDS epidemic, someone is newly infected...May 18, HIV Vaccine Awareness Day, AIDS Action, on...ute of Allergy and Infectious,Disease (NIAID) HIV ...one,to help end the AIDS epidemic by participating...
(Date:5/16/2008)... most from chemo after surgery, study says , ...of 15 genes may help determine which patients with...ience a recurrence and, therefore, benefit the mos...xtension, the same genetic signature may also iden...ncer who would be able to forego chemotherapy. ,...
(Date:5/16/2008)...th plc (LSE: HNT), "the Group",a leading internat...ns,group headquartered in London, released its int... performance in the first quarter 2008 (the period... below., 15 May 2008, ...nagement Statement, Record net new bus...
(Date:5/16/2008)...arn the lesson of helping others i...ina, May 16 /PRNewswire/ -- In the aftermath of th...t members of China are,looking for ways to join in...ountry, schools are running donation drives and fu...l, Ms. Zhang Lijun, the 190-student strong,Nanjing...
Breaking Medicine News(10 mins):Health News:AIDS Action Urges Everyone to Help End the AIDS Epidemic by Being Part of the Search for an HIV Vaccine 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 4Health News:Chinese Preschoolers Participate in Fund Drive to Help the Victims of Sichuan Quake 2
...'s B.M. Birla Heart Research Centre Friday became ...ccreditation// in recognition of its high quality ...r Hospitals and Health Service Providers (NABH) ce...nt of our focus on quality", Suyash Borar, the hos...
...e of the biggest controversies in fetal surgery an...ternal-fetal medicine physicians// around the worl...ion syndrome (TTTS), one of the most common condit...eading cause of mortality in twins? The benchmark...
...ne Sherwood-Puzzello, a clinical assistant profess...of Applied Health Science//, has offered some tips...on sex with their teenage children. Teenage is th...of growing up. Love and romance form an integral p...
...rch aimed to study the significance of thyroid che...searchers are considering whether thyroid check up...if no symptoms of the disease are seen. Previous s...y under active or a hyperactive thyroid gland duri...
Other Medicine News:Health News:Timeliness, a Critical Factor in Treating TTTS 2Health News:Timeliness, a Critical Factor in Treating TTTS 3Health News:Pregnant? Check Your Thyroid Secretion! 2
(Date:5/15/2008)...hase II Data Presented at ASCO Showed Acceptable T...e of Grade 3 and 4 Neuropathy, WOODCLIFF LAKE, N....motherapeutic agent eribulin mesylate (E7389) demo...on of women with locally advanced or metastatic,br...r Phase II clinical,trial. The study also suggests...
(Date:5/15/2008)... - Unprecedented amount of research reflects dep...rs worldwide to develop new treatments for ...y session to highlight impact of Zometa(R), the le...nts with early-stage breast cancer, - Four oral s...ontinuous, inhibitor of mTOR, including first resu...
(Date:5/15/2008)...od pressure reductions demonstrated in Blacks, His...tes and Obese Individuals, PARSIPPANY, N.J., May ... today that data presented at the American Society... Meeting (ASH 2008) in New,Orleans demonstrated th...ine and olmesartan medoxomil) safely and effective...
(Date:5/15/2008)...Excellent results obtained with a newly cleared de... plaques of interest that are associated with ... BURLINGTON, Mass., May 15 /- InfraRe...nt Hospital in Royal Oak, Mich., have,successfully...a patient,undergoing a cardiac catheterization. Th...
Breaking Medicine Technology:Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4Synvista Therapeutics Announces Initiation of Phase 2 Study With Alagebrium for Chronic Heart Failure 827 1Synvista Therapeutics Announces Initiation of Phase 2 Study With Alagebrium for Chronic Heart Failure 827 2Synvista Therapeutics Announces Initiation of Phase 2 Study With Alagebrium for Chronic Heart Failure 827 3Synvista Therapeutics Announces Initiation of Phase 2 Study With Alagebrium for Chronic Heart Failure 827 4The Ultimate Stress Reliever SpaCapsule 28R 29 the Capsule that Takes You on a Rejuvenating Journey to the Spa Retains TransMedia Group for Soothin 6056 1The Ultimate Stress Reliever SpaCapsule 28R 29 the Capsule that Takes You on a Rejuvenating Journey to the Spa Retains TransMedia Group for Soothin 6056 2Fuwei Films Announces Third Quarter 2007 Financial Results 6052 1Fuwei Films Announces Third Quarter 2007 Financial Results 6052 2Fuwei Films Announces Third Quarter 2007 Financial Results 6052 3Fuwei Films Announces Third Quarter 2007 Financial Results 6052 4Fuwei Films Announces Third Quarter 2007 Financial Results 6052 5Fuwei Films Announces Third Quarter 2007 Financial Results 6052 6World Diabetes Day Lights Up the Skyline 6048 1World Diabetes Day Lights Up the Skyline 6048 2World Diabetes Day Lights Up the Skyline 6048 3
...at the Movement Disorder Society,s 11th,Internatio..., June 08, 2007 /PRNewswire-FirstCall/ -- New,info...ts) for the,treatment of Parkinson,s disease (PD) ...ciety,s congress in Istanbul, Turkey.,Once-daily A...he,treatment of the signs and symptoms of PD, both...
...xas, June 08, 2007 /PRNewswire-FirstCall/ --,Lexic...cation of,new findings from a joint research proje...hiladelphia, PA. Together with David L.,Wiest, Ph....d,surprising role for ribosomal protein L22 (Rpl22...ngs have been published in,the June issue of the j...
Other Medicine Technology:International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 2International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 3International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 4International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 5International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 6Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune,Deficiency 2Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune,Deficiency 3
Designed as an excellent form of primary suspension
...enefits of controlled compression and cold, the Ca... pain. The anatomically designed cuff provides com...yo/Cuffs can be ordered as a single cuff, or with ... disk). The Cooler is available separately and can...
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
...Splint provides effective long-term stabilization ...le radial and palmar stays immobilize wrist and th...caphoid and soft tissue injuries. D-ring contact c...ior fit and unparalleled comfort. Padding thicknes...
Medicine Products: